162 related articles for article (PubMed ID: 34104028)
1. Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates.
Nativi-Nicolau J; Sarswat N; Fajardo J; Finkel M; Abdulsattar Y; Castaño A; Klein L; Haddad-Angulo A
Clin Med Insights Cardiol; 2021; 15():11795468211015230. PubMed ID: 34104028
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis: A survey of current awareness, diagnostic modalities, treatment practices, and clinical challenges among cardiologists in selected Middle Eastern countries.
Mohty D; Nasr S; Ragy H; Farhan HA; Fadel B; Alayary I; Ghoubar M
Clin Cardiol; 2023 Jun; 46(6):648-655. PubMed ID: 37038634
[TBL] [Abstract][Full Text] [Related]
3. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Rintell D; Heath D; Braga Mendendez F; Cross E; Cross T; Knobel V; Gagnon B; Turtle C; Cohen A; Kalmykov E; Fox J
Orphanet J Rare Dis; 2021 Feb; 16(1):70. PubMed ID: 33557882
[TBL] [Abstract][Full Text] [Related]
4. The patient pathway in ATTR-CM in Greece and how to improve it: A multidisciplinary perspective.
Apostolou EA; Fontrier AM; Efthimiadis GK; Kastritis E; Parissis J; Kanavos P
Hellenic J Cardiol; 2023; 73():73-80. PubMed ID: 37201632
[TBL] [Abstract][Full Text] [Related]
5. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
Gertz M; Adams D; Ando Y; Beirão JM; Bokhari S; Coelho T; Comenzo RL; Damy T; Dorbala S; Drachman BM; Fontana M; Gillmore JD; Grogan M; Hawkins PN; Lousada I; Kristen AV; Ruberg FL; Suhr OB; Maurer MS; Nativi-Nicolau J; Quarta CC; Rapezzi C; Witteles R; Merlini G
BMC Fam Pract; 2020 Sep; 21(1):198. PubMed ID: 32967612
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland.
Mircsof D
Cardiol Ther; 2020 Jun; 9(1):127-138. PubMed ID: 31960349
[TBL] [Abstract][Full Text] [Related]
7. Best Practices in Nuclear Imaging for the Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in KSA: The Eagle Eyes of Local Experts.
Alqarni A; Aljizeeri A; Bakhsh AM; El-Zeftawy HAM; Farghaly HR; Alqadhi MAM; Algarni M; Asiri ZM; Osman A; Haddadin H; Alayary I; Al-Mallah MH
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248088
[TBL] [Abstract][Full Text] [Related]
8. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers.
Stewart M; Shaffer S; Murphy B; Loftus J; Alvir J; Cicchetti M; Lenderking WR
Neurol Ther; 2018 Dec; 7(2):349-364. PubMed ID: 30073497
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.
Yadav JD; Othee H; Chan KA; Man DC; Belliveau PP; Towle J
Ann Pharmacother; 2021 Dec; 55(12):1502-1514. PubMed ID: 33685242
[TBL] [Abstract][Full Text] [Related]
11. Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
Choy CH; Steeds RP; Pinney J; Baig S; Turvey-Haigh L; Wahid Y; Cox H; Zaphiriou A; Srinivasan V; Wilson D; Fryearson J; Ahamed M; Lim S; Chue C; Pratt G; Fontana M; Gillmore JD; Moody WE
Clin Med (Lond); 2024 Jan; 24(1):100004. PubMed ID: 38377730
[TBL] [Abstract][Full Text] [Related]
12. A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit.
Bueno Juana E; Gracia Gutiérrez A; Melero Polo J; Roteta Unceta-Barrenechea A; Andrés Gracia A; Lahuerta Pueyo C; Menao Guillén S; Revilla Martí P; Aibar Arregui MÁ
Rev Clin Esp (Barc); 2022 Mar; 222(3):161-168. PubMed ID: 34563487
[TBL] [Abstract][Full Text] [Related]
13. Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy.
Dale Z; Al-Rashdan L; Elman M; Chandrashekar P; Heitner SB; Nazer B; Masri A
Int J Cardiol; 2022 Feb; 349():99-102. PubMed ID: 34843821
[TBL] [Abstract][Full Text] [Related]
14. Native T1 mapping in transthyretin amyloidosis.
Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
[TBL] [Abstract][Full Text] [Related]
15. Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.
Rozenbaum MH; Large S; Bhambri R; Stewart M; Whelan J; van Doornewaard A; Dasgupta N; Masri A; Nativi-Nicolau J
Cardiol Ther; 2021 Jun; 10(1):141-159. PubMed ID: 33877591
[TBL] [Abstract][Full Text] [Related]
16. Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.
Irabor B; McMillan JM; Fine NM
Front Cardiovasc Med; 2022; 9():863179. PubMed ID: 35656395
[TBL] [Abstract][Full Text] [Related]
17. Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis.
Aimo A; Rapezzi C; Perfetto F; Cappelli F; Palladini G; Obici L; Merlini G; Di Bella G; Serenelli M; Zampieri M; Milani P; Licordari R; Teresi L; Ribarich N; Castiglione V; Quattrone F; De Rosis S; Vergaro G; Panichella G; Emdin M; Passino C
Eur J Clin Invest; 2021 Nov; 51(11):e13598. PubMed ID: 33982288
[TBL] [Abstract][Full Text] [Related]
18. Amyloidosis in Heart Failure.
Ihne S; Morbach C; Obici L; Palladini G; Störk S
Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
[TBL] [Abstract][Full Text] [Related]
19. Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis-A Survey-Based Study.
Stan C; Mititelu R; Adam RD; Jurcuţ R
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204645
[TBL] [Abstract][Full Text] [Related]
20. Preclinical diagnosis of wild-type transthyretin amyloid cardiomyopathy in a patient undergoing carpal tunnel release.
Nakashima N; Takashio S; Morioka M; Nishi M; Hirakawa K; Hanatani S; Masuda T; Ueda M; Tsujita K
J Cardiol Cases; 2021 Nov; 24(5):250-253. PubMed ID: 34868409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
